Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Mr. Robert John DayVP of Development | -6,19k | 40,14k | Derivative Exercise and Sale | 2,13 - 8,61 | 90,28k | - |
| 2026-05-27 | Mr. Robert John DayVP of Development | 6,68k | 14,19k | Derivative Exercise and Retained Stock | 2,13 | 90,28k | 7,98% |
| 2026-05-12 | Mr. Robert John DayVP of Development | -2,39k | 22,71k | Vente | 9,50 | 83,61k | -2,78% |
| 2026-05-12 | Mr. Robert John DayVP of Development | 4,97k | 15,24k | Derivative Exercise and Retained Stock | 3,07 | 83,61k | 6,32% |
| 2026-05-12 | Mr. OJay PlattVP of Production | -5,58k | 53,05k | Vente | 9,50 | 122,31k | -4,36% |
| 2026-05-12 | Mr. OJay PlattVP of Production | 11,60k | 35,59k | Derivative Exercise and Retained Stock | 3,07 | 122,31k | 10,48% |
| 2026-03-15 | Dr. Fotis KalantzisPresident, CEO & Director | 2,20k | 15,46k | Acquisition Under Employee Benefit Plan | 7,03 | 8,42M | 0,03% |
| 2026-03-15 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | 1,43k | 10,04k | Acquisition Under Employee Benefit Plan | 7,03 | 255,61k | 0,56% |
| 2026-03-15 | Mr. Martin MalekCOO | 1,43k | 10,04k | Acquisition Under Employee Benefit Plan | 7,03 | 377,66k | 0,38% |
| 2026-03-15 | Mr. OJay PlattVP of Production | 1,27k | 8,92k | Acquisition Under Employee Benefit Plan | 7,03 | 116,29k | 1,10% |
| 2026-03-15 | Mr. Robert John DayVP of Development | 1,20k | 8,41k | Acquisition Under Employee Benefit Plan | 7,03 | 81,03k | 1,50% |
| 2026-03-06 | Mr. OJay PlattVP of Production | -7,00 | 54,69 | Vente | 7,81 | 115,02k | -0,01% |
| 2026-03-02 | Mr. Reginald James GreensladeIndependent Director | 9,60k | 21,91k | Derivative Exercise and Retained Stock | 2,28 | 2,25M | 0,43% |
| 2026-03-02 | Mr. Reginald James GreensladeIndependent Director | -5,15k | 41,17k | Vente | 7,99 | 2,25M | -0,23% |
| 2026-03-02 | Mr. Donald F. ArchibaldIndependent Director | -9,60k | 54,82k | Derivative Exercise and Sale | 2,28 - 7,99 | 2,27M | - |
| 2026-03-02 | Mr. Richard Francis McHardyChairman | 9,60k | 21,91k | Derivative Exercise and Retained Stock | 2,28 | 7,10M | 0,14% |
| 2026-03-02 | Mr. Richard Francis McHardyChairman | -4,62k | 36,94k | Vente | 7,99 | 7,10M | -0,07% |
| 2026-03-02 | Dr. Fotis KalantzisPresident, CEO & Director | 159,73k | 364,62k | Derivative Exercise and Retained Stock | 2,28 | 8,42M | 1,93% |
| 2026-03-02 | Dr. Fotis KalantzisPresident, CEO & Director | -76,88k | 614,52k | Vente | 7,99 | 8,42M | -0,90% |
| 2026-03-02 | Ms. Tamara L. MacDonaldIndependent Director | -9,60k | 54,82k | Derivative Exercise and Sale | 2,28 - 7,99 | 979,69k | - |
| 2026-03-02 | Mr. Martin MalekCOO | 55,90k | 127,60k | Derivative Exercise and Retained Stock | 2,28 | 376,23k | 17,45% |
| 2026-03-02 | Mr. Martin MalekCOO | -26,91k | 215,06k | Vente | 7,99 | 376,23k | -6,67% |
| 2026-03-02 | Mr. OJay PlattVP of Production | 20,33k | 46,41k | Derivative Exercise and Retained Stock | 2,28 | 115,03k | 21,47% |
| 2026-03-02 | Mr. OJay PlattVP of Production | -9,79k | 78,23k | Vente | 7,99 | 115,03k | -7,84% |
| 2026-03-02 | Mr. Robert John DayVP of Development | 13,07k | 29,83k | Derivative Exercise and Retained Stock | 2,28 | 79,84k | 19,57% |
| 2026-03-02 | Mr. Robert John DayVP of Development | -6,29k | 50,28k | Vente | 7,99 | 79,84k | -7,30% |
| 2026-03-02 | Mr. Kevin R. OverstromIndependent Director | 9,60k | 21,91k | Derivative Exercise and Retained Stock | 2,28 | 1,92M | 0,50% |
| 2026-03-02 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | 28,99k | 66,18k | Derivative Exercise and Retained Stock | 2,28 | 254,19k | 12,88% |
| 2026-03-02 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | -26,91k | 153,64k | Derivative Exercise and Sale | 2,28 - 7,99 | 254,19k | - |
| 2026-02-27 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | -13,00k | 104,78k | Vente | 8,06 | 225,19k | -5,46% |
| 2026-02-25 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | 40,97k | 109,03k | Derivative Exercise and Retained Stock | 2,66 | 238,19k | 20,77% |
| 2026-02-25 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | -38,03k | 187,67k | Derivative Exercise and Sale | 2,66 - 7,60 | 238,19k | - |
| 2026-02-25 | Mr. Randy Murray BergInitié | -33,06k | 251,10k | Vente | 7,60 | 264,70k | -11,10% |
| 2026-02-25 | Mr. Robert John DayVP of Development | 12,07k | 32,11k | Derivative Exercise and Retained Stock | 2,66 | 73,06k | 19,78% |
| 2026-02-25 | Mr. Robert John DayVP of Development | -11,20k | 55,27k | Derivative Exercise and Sale | 2,66 - 7,60 | 73,06k | - |
| 2026-02-25 | Mr. Reginald James GreensladeIndependent Director | 4,14k | 11,02k | Derivative Exercise and Retained Stock | 2,66 | 2,25M | 0,18% |
| 2026-02-25 | Mr. Reginald James GreensladeIndependent Director | -4,79k | 23,65k | Derivative Exercise and Sale | 2,66 - 7,60 | 2,25M | - |
| 2026-02-25 | Mr. Donald F. ArchibaldIndependent Director | -8,93k | 44,08k | Derivative Exercise and Sale | 2,66 - 7,60 | 2,27M | - |
| 2026-02-25 | Mr. Kevin R. OverstromIndependent Director | 8,93k | 23,77k | Derivative Exercise and Retained Stock | 2,66 | 1,91M | 0,47% |
| 2026-02-25 | Mr. Richard Francis McHardyChairman | 4,63k | 12,33k | Derivative Exercise and Retained Stock | 2,66 | 7,09M | 0,07% |
| 2026-02-25 | Mr. Richard Francis McHardyChairman | -4,30k | 21,23k | Derivative Exercise and Sale | 2,66 - 7,60 | 7,09M | - |
| 2026-02-25 | Dr. Fotis KalantzisPresident, CEO & Director | 85,49k | 227,50k | Derivative Exercise and Retained Stock | 2,66 | 8,34M | 1,04% |
| 2026-02-25 | Dr. Fotis KalantzisPresident, CEO & Director | -79,35k | 391,58k | Derivative Exercise and Sale | 2,66 - 7,60 | 8,34M | - |
| 2026-02-25 | Ms. Tamara L. MacDonaldIndependent Director | -8,93k | 44,08k | Derivative Exercise and Sale | 2,66 - 7,60 | 979,69k | - |
| 2026-02-25 | Mr. Randy Murray BergInitié | 68,67k | 182,74k | Derivative Exercise and Retained Stock | 2,66 | 264,70k | 35,03% |
| 2026-02-25 | Mr. Martin MalekCOO | 46,31k | 123,25k | Derivative Exercise and Retained Stock | 2,66 | 347,24k | 15,39% |
| 2026-02-25 | Mr. Martin MalekCOO | -42,99k | 212,15k | Derivative Exercise and Sale | 2,66 - 7,60 | 347,24k | - |
| 2026-02-25 | Mr. OJay PlattVP of Production | 28,49k | 75,82k | Derivative Exercise and Retained Stock | 2,66 | 104,48k | 37,49% |
| 2026-02-25 | Mr. OJay PlattVP of Production | -26,44k | 130,50k | Derivative Exercise and Sale | 2,66 - 7,60 | 104,48k | - |
| 2026-02-25 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | 88,30k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 7,56 | 439,10k | 25,17% |
| 2026-02-25 | Mr. Martin MalekCOO | 104,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 7,56 | 579,30k | 21,88% |
| 2026-02-25 | Mr. OJay PlattVP of Production | 52,80k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 7,56 | 278,60k | 23,38% |
| 2026-02-25 | Mr. Robert John DayVP of Development | 51,90k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 7,56 | 342,60k | 17,85% |
| 2026-02-25 | Mr. Reginald James GreensladeIndependent Director | 10,10k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 7,56 | 58,20k | 21,00% |
| 2026-02-25 | Mr. Donald F. ArchibaldIndependent Director | 10,10k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 7,56 | 58,20k | 21,00% |
| 2026-02-25 | Mr. Kevin R. OverstromIndependent Director | 10,10k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 7,56 | 58,20k | 21,00% |
| 2026-02-25 | Mr. Richard Francis McHardyChairman | 11,90k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 7,56 | 60,00k | 24,74% |
| 2026-02-25 | Ms. Tamara L. MacDonaldIndependent Director | 10,10k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 7,56 | 58,20k | 21,00% |
| 2026-01-22 | Mr. OJay PlattVP of Production | -8,00 | 51,01 | Vente | 6,38 | 75,99k | -0,01% |
| 2026-01-09 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | 26,81k | 144,71k | Achat | 5,40 | 197,22k | 15,73% |
| 2026-01-07 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | -50,00k | 263,67k | Vente | 5,27 | 197,22k | -20,22% |
| 2025-12-31 | Dr. Fotis KalantzisPresident, CEO & Director | 3,72k | 18,23k | Acquisition Under Employee Benefit Plan | 4,90 | 8,24M | 0,05% |
| 2025-12-31 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | 2,42k | 11,85k | Acquisition Under Employee Benefit Plan | 4,90 | 220,41k | 1,11% |
| 2025-12-31 | Mr. Randy Murray BergInitié | 2,61k | 12,76k | Acquisition Under Employee Benefit Plan | 4,90 | 229,09k | 1,15% |
| 2025-12-31 | Mr. Martin MalekCOO | 2,42k | 11,85k | Acquisition Under Employee Benefit Plan | 4,90 | 300,93k | 0,81% |
| 2025-12-31 | Mr. OJay PlattVP of Production | 2,16k | 10,57k | Acquisition Under Employee Benefit Plan | 4,90 | 76,00k | 2,92% |
| 2025-12-31 | Mr. Robert John DayVP of Development | 2,01k | 9,85k | Acquisition Under Employee Benefit Plan | 4,90 | 60,99k | 3,41% |
| 2025-09-30 | Dr. Fotis KalantzisPresident, CEO & Director | 5,11k | 17,95k | Acquisition Under Employee Benefit Plan | 3,51 | 8,25M | 0,06% |
| 2025-09-30 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | 3,32k | 11,66k | Acquisition Under Employee Benefit Plan | 3,51 | 217,99k | 1,55% |
| 2025-09-30 | Mr. Randy Murray BergInitié | 3,58k | 12,56k | Acquisition Under Employee Benefit Plan | 3,51 | 226,49k | 1,61% |
| 2025-09-30 | Mr. Martin MalekCOO | 3,32k | 11,66k | Acquisition Under Employee Benefit Plan | 3,51 | 298,51k | 1,13% |
| 2025-09-30 | Mr. OJay PlattVP of Production | 2,97k | 10,41k | Acquisition Under Employee Benefit Plan | 3,51 | 73,84k | 4,18% |
| 2025-09-30 | Mr. Robert John DayVP of Development | 2,76k | 9,69k | Acquisition Under Employee Benefit Plan | 3,51 | 58,98k | 4,91% |
| 2025-06-30 | Dr. Fotis KalantzisPresident, CEO & Director | 8,02k | 18,44k | Acquisition Under Employee Benefit Plan | 2,30 | 8,24M | 0,10% |
| 2025-06-30 | Mr. Randy Murray BergInitié | 5,61k | 12,91k | Acquisition Under Employee Benefit Plan | 2,30 | 222,91k | 2,58% |
| 2025-08-11 | Mr. Martin MalekCOO | 50,17k | 157,19k | Derivative Exercise and Retained Stock | 3,13 | 295,18k | 20,47% |
| 2025-06-30 | Mr. Martin MalekCOO | 5,21k | 11,99k | Acquisition Under Employee Benefit Plan | 2,30 | 295,18k | 1,80% |
| 2025-08-11 | Mr. OJay PlattVP of Production | 16,33k | 51,18k | Derivative Exercise and Retained Stock | 3,13 | 70,88k | 29,94% |
| 2025-06-30 | Mr. OJay PlattVP of Production | 4,65k | 10,69k | Acquisition Under Employee Benefit Plan | 2,30 | 70,88k | 7,02% |
| 2025-08-11 | Mr. Robert John DayVP of Development | 1,73k | 5,41k | Derivative Exercise and Retained Stock | 3,13 | 56,22k | 3,17% |
| 2025-06-30 | Mr. Robert John DayVP of Development | -8,31k | 4,76k | Derivative Exercise and Sale | 2,30 - 3,71 | 56,22k | - |
| 2025-06-30 | Mr. Robert John DayVP of Development | 2,63k | 6,04k | Acquisition Under Employee Benefit Plan | 2,30 | 56,22k | 4,90% |
| 2025-08-11 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | 13,37k | 41,88k | Derivative Exercise and Retained Stock | 3,13 | 214,67k | 6,64% |
| 2025-06-30 | Mr. Ronald Andrew WilliamsVP of Finance & CFO | 5,21k | 11,99k | Acquisition Under Employee Benefit Plan | 2,30 | 214,67k | 2,49% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.